<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> (LMWH) has similar efficacy to unfractionated <z:chebi fb="5" ids="28304">heparin</z:chebi> with less hemorrhagic complications </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the neuroprotective effect of LMWH on a rat model of focal-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Our results revealed that treatment with LMWH at 1 and 3 h following thrombotic <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion reduced <z:hpo ids='HP_0002181'>brain edema</z:hpo> and <z:mpath ids='MPATH_124'>infarct</z:mpath> size and improved clinical outcome </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment with LMWH initiated at 6 h after thrombin injection only partially ameliorated brain damage </plain></SENT>
</text></document>